New Ray Medicine International Holding Ltd Sustainability Reports
The company is principally engaged in the distribution and trading of pharmaceutical products, chemical reagents, and related medical products in the PRC. It also provides marketing and promotion services for drugs to healthcare suppliers and end customers.
Sector: Wholesale & retail
Country: China
Exchange: Hong Kong Stock Exchange
10 reports from 2020 to 2025
- New Ray Medicine International Holding Ltd 2025 Annual Report
- New Ray Medicine International Holding Ltd 2025 Annual Report
- New Ray Medicine International Holding Ltd 2024 Annual Report
- New Ray Medicine International Holding Ltd 2023 Annual Report
- New Ray Medicine International Holding Ltd 2023 Annual Report